Clinical Trial Update: Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessed the efficacy and safety of esomeprazole once daily for gastroesophageal reflux disease in neonates. The study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Phase 3 | Status: COMPLETED | Results posted: 2010-05-19